# Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo

> **NCT01246921** · PHASE4 · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 50 (estimated)

## Conditions studied

- Patients With Active Non-segmental Vitiligo.
- Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%
- Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo

## Interventions

- **DRUG:** Fluticasone proprionate 0.05% cream

## Key facts

- **NCT ID:** NCT01246921
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2011-08
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246921, "Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01246921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*